High PD-L1 expression, defined as staining in 50% or more tumor cells on immunohistochemistry, is significantly less prevalent in EGFR-mutated tumors (15.5%) compared to EGFR wild-type tumors (31%) [9]. The gene discussed is EGFR; the disease is neoplasm.